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Introduction
Embryonic stem cells (ESCs) are derived from the inner cell mass (ICM) of blastocysts. They are capable of unlimited self-renewal, as well as proliferation, and maintain pluripotency in vitro to differentiate into all three germ layers endoderm, mesoderm, and ectoderm, as the most primitive stem cells. Thus, ESCs have great potential applications in regenerative medicine and serve as model to study molecular embryogenesis [1] . Consequently, in recent decades ESCs have become one of the research hotspots in many fields of medical research [2] .
The proliferation ability is one of the interests in ESCs research, which is mainly focused on the exogenous/endogenous transcription factors, signal pathway molecules, small molecular synthetic material, and gene regulations. The proliferation ability of ESCs is closely related to the regulation of ESC cell cycle, and ESCs are characterized with a short G1 period [3] . Some of the somatic cells like bone marrow, liver, and skin cells, have a greater regeneration and proliferation potential with short G1 period, while most of the other somatic cells regeneration potential is considered to be low with a long quiescent G0 phase and the proliferation ability is regarded as poor [3] . Cell cycle regulation has two main restriction point, G1/S restriction point and G2/M restriction point. It has been shown that microRNAs (miRNAs) can regulate cell cycle-related gene expression of transcription factors regulatory pathways and thus affect stem cell self-renewal, proliferation and differentiation, maintaining the balance of two biological processes [4] . These specific cell-cycle regulating miRNAs in ESCs are known as Embryonic Stem cell-specific Cell Cycle-regulating miRNAs (ESCC-miRNAs) [5] , in which the miR-290 cluster in mESCs is highly profiled and plays an important role in the proliferation of mESCs [3] .
Two types of genes, oncogenes and cancer suppressor genes, are related to cell proliferation. Activation of oncogenes leads to increased expression of genes that promote cell cycle progression and cell proliferation. Because some of them already exist in the cell, they are called proto-oncogene [6] . The proto-oncogenes, c-myc, c-fos, and c-jun, are early response proteins that regulates cell cycle genes. They can promote positive regulators of cell cycle such as Cyclin and Cdk binding [7] which usher the cell into the cell cycle and are usually considered as promoters of G1/S restriction point in the process. Whether c-jun and c-fos can act as detectors of cell proliferation genes and can play important roles in ESCs proliferation and differentiation remains unexplored.
In China, traditional Chinese medicines (TCMs) have been used for the treatment of various types of diseases for thousands of years. Moreover, some studies have revealed that the active components of TCMs have the ability to influence stem cell proliferation, differentiation and apoptosis [8] [9] [10] [11] [12] . These active components regulate either the transcription factors [13] or the cell cycle-related genes thereby affecting stem cell differentiation, proliferation and apoptosis. Our previous data have revealed that TCMs baicalin, puerarin and ginsenoside Rg1 influence the cardiac differentiation of mESCs [14] [15] [16] by changing the expression of the cardiac-specific transcriptional factors. Whether they could also exert effects on mESCs proliferation by modifying the expression of mESC-miRNAs remains to be determined. Thus we aimed to explore this possibility. The obtained data showed that baicalin suppressed the proliferation of ESCs by regulating the expression of proto-oncogenes c-fos and c-jun via miR-294 downregulation.
Materials and Methods

Cell Culture of mESCs
The mouse embryonic stem cell line D3 (D3-mESCs) was obtained from ATCC (Manassas, USA) and cultured using Dulbecco's modified Eagle's medium (DMEM) (Gibco, USA) supplemented with 15% (v/v) fetal bovine serum (FBS) (Gibco, USA), 2 mM L-glutamine (Gibco/Invitrogen, USA), 50 mM β-mercaptoethanol (Gibco/Invitrogen, USA), 1x non-essential amino acids (Gibco/Invitrogen, USA) and 100 IU/ml penicillin/streptomycin(Gibco/Invitrogen, USA) at 37 ˚C and 5% CO 2 . ESCs were cultured on a 
Cell Proliferation Assays
Cell proliferation was examined 48 h after inoculation with a cell proliferation assay using Cell Counting Kit-8 (CCK-8) (DOJINDO, Japan) according to the manufacturer's instructions. Briefly, cells were seeded in 96-well plates at 1000 cells/well with 100 μl 15% DMEM, and after 48 h, 10 μl CCK-8 solution/ well was added. The optical density was measured using the microplate reader at a wavelength of 450 nm.
Cell Cycle Assay
Propidium iodide (PI) staining was used to visualize cell cycle. Approximately 1×10 6 cells were pelleted by centrifugation at 1500 r.p.m. for 5 min, washed with 1 ml cold Dulbecco's phosphate-buffered saline (PBS) without MgCl 2 or CaCl 2 thereafter processed for cell cycle analysis. Cells were resuspended in 4 ml cold 70 % ethanol at 4 ˚C for 1 h, then centrifuged at 1500 r.p.m. for 5 min. The pellet was washed with cold PBS, re-suspended in 500 μl PBS, and incubated with 10 μl 1mg/ml RNase (20 μg/ml final concentration) for 30 min. The cells were incubated with propidium iodide (50 mg/ml) on ice for 1 h in the dark. The cell cycle distribution was analyzed using FACS Caliber instrument (BD Biosciences, San Jose, CA, USA). Nuclear debris and overlapping nuclei were gated out.
RNA Isolation and Revere Transcription
Total RNA including miRNAs was extracted from ESCs using TRIzol (Invitrogen, USA). Revere transcription was performed on 2 ng of total RNA. Briefly, 2 ng of total RNA was reverse transcribed to cDNA. First strand cDNA of proto-oncogenes was synthesized by using M-MLV reverse transcriptase (Invitrogen, USA) with dT (18) oligo, and the First strand cDNA of miRNAs was synthesized by using M-MLV reverse transcriptase (Invitrogen, USA) with specific stem loop miRNA RT Primer (Ribo, China).
Real-time PCR
For real-time quantitative RT-PCR of c-myc, c-fos, c-jun and GAPDH, the SYBR-Green PCR MasterMix (TOYOBO CO., LTD, Japan) was used with gene-specific primers listed in Table 1 . Real-time quantitative PCR was performed using 1.6 μl the first strand cDNA, 0.4 μl 10 mM forward and reverse primers, 10 μl SYBRGreen PCR MasterMix to total 20 μl volume. The PCR processing consisted of 40 cycles of 10 s denaturation at 95°C, 20 s annealing at 60°C, and 15 s extension at 72°C. All reactions were run in triplicate. For real-time quantitative PCR of miR-294, miR-295, miR-291a, miR-291b, miR-93 and U6, the SYBR-Green PCR MasterMix was used with stem loop miRNA primers (Ribo, China). Reaction and signal detection were measured by Mx3000P real-time PCR system (Agilent Stratagene, USA). The CT values of proto-oncogenes and miRNAs were converted into absolute copy numbers using a standard curve for GAPDH and U6 miRNA, respectively.
Overexpression of miRNA-294
A single-cell suspension of 2×10 5 mESCs was plated in the tissue culture dishes to achieve a 50~60% confluence for approximately 24 h. Once the confluence was achieved, the adherent cells were transfected using Lipofectamine TM 2000 (Invitrogen, USA), with mmu-miR-294 mimic (Ribo, China) or empty vector Table 1 . Primers used for real time RT-PCR (control) in OPTI-MEM (Gibco, USA) according to the manufacturer's instruction. After 2 days of cell culture, the cells were trypsinized and collected for further experiments.
Agents
Baicalin, puerarin, and ginsenoside Rg1 were purchased from Nanjing Qingze Medical Technology Co., Ltd, dissolved in dimethyl sulfoxide (DMSO, Sigma Co.) to stock concentrations, and stored at -20 ℃ in the dark.
Results
Baicalin Suppressed mESCs Proliferation
We first examined whether the three different TCMs, baicalin, ginsenoside Rg1, and puerarin, could influence the proliferation of mESCs. Dose dependent effects of each TCM were tested (data not shown) and the dose of maximum effects was applied in the following experiments. As shown in Fig. 1A , baicalin 50 μM suppressed the proliferation of mESCs to 0.55 ± 0.04 of control (p<0.01, n=14), while ginsenoside Rg1 10 μM (1.00 ± 0. 03 of control, p>0.05, n=10) and puerarin 100 μM had no significant effects on the proliferation of mESCs (1.03±0.03 of control, p>0.05, n=10).
The cell cycle analysis on mESCs showed that most of mESCs distributed in S phase (65.15±2.42%) and less mESCs in G1 (17.31±1.82%) and G2/M phases (17.54±2.09%). Baicalin 50 μM accumulated more mESCs in G1 phase (up to 28.20±2.33%, p<0.05, n=4) and less cells in S phase (down to 56.25±3.95%, p<0.05, n=4) and G2/M phase (down to 15.55±1.95%, p>0.05, n=4) (Fig. 1B) . Neither Rg1 (10 μM) nor puerarin (100 μM) changed the cell distribution significantly (Fig. 1C-D) .
The above observations in the three TCMs were paralleled well with the expression level of proto-oncogenes c-myc, c-jun and c-fos (Fig. 2) . The expressions of c-jun and c-fos were suppressed by baicalin 50 μM to 27.29 ± 0.05% and 55.08 ± 0.06% vs. control (p<0.01, n=5), respectively ( Fig. 2A) . In contrast, neither ginsenoside Rg1 10 μM (Fig. 2B ) nor puerarin 100 μM (Fig. 2C) significantly influenced the expressions of the three proto-oncogenes (p>0.05 vs. 0.05% DMSO, n=5). Therefore these data suggested that in the three tested TCMs, baicalin 
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was the only one which significantly suppressed the mESC proliferation. Such suppression was accompanied with the G1 arrest, S stage suppression, and the down-regulation of protooncogenes c-jun and c-fos.
Baicalin downregulated miR-294 Expression in mESCs
MiR-290 cluster participates in regulating the proliferation of mESCs and some drugs might directly influence the expression level of miRNAs, thus we next investigated whether the TCMs affect the proliferation of mESCs by miR-290 cluster. The results showed that baicalin 50 μM obviously downregulated the expression of miR-294 to 30.39±9.21% compared with (Fig. 3A) . Meanwhile, ginsenoside Rg1 10 μM and puerarin 100 μM did not significantly alter the expressions of each member of miR-290 cluster (p>0.05, n=4). (Fig. 3B-C) . This strongly indicated that baicalin might inhibit mESC proliferation by downregulating miR-294.
Overexpression of miR-294 in mESCs Reversed the Alterations in the mESC Proliferation and the Expression of c-jun and c-fos Induced by Baicalin
To determine whether miR-294 is essential in baicalin-induced changes in mESCs, we transfected mESCs with miR-294 mimic by lipofectamin 2000 TM . With lipofectamin 2000 TM transfection the miR-294 mimic to mESCs for 24 h, the expression of miR-294 was upregulated to 40.97 ± 4.44 folds vs. vector control (p<0.01, n=4). The miR-294 expression in baicalin and miR-294 co-treated group was upregulated to 7.71±1.78 folds vs. vector control (p<0.01, n=4), suggesting that baicalin indeed inhibited miR-294 expression and the miR-294 transfection rescued the downregulation of miR-294 by baicalin (Fig. 4A) .
With overexpression of miR-294, the proliferation was elevated up to 1.22±0.05 vs. vector control (p<0.01, n=4), as well as reversed the proliferation of baicalin treated group from 0.67±0.05 to 0.85±0.06 (p<0.05, n=4) (Fig. 4B) . Moreover, the overexpression of miR-294 upregulated the expression of c-jun and c-fos by 2.56±0.12 and 2.65±0.14 folds vs. vector control, respectively (p<0.01, n=4), and rescued the downregulation of these genes induced by baicalin from 0.66±0.05 to 1.44 ± 0.02, and from 0.55±0.07 to 1.81±0.02 fold vs. vector control (p<0.01, n=4) (Fig. 4C ) for c-jun and c-fos respectively.
Discussion
Traditional Chinese medicines (TCMs) and their active ingredients have been reported to regulate the biological processes such as proliferation, differentiation and apoptosis by the regulation of gene expression of transcription factors and cytokines [7, 9] . In the present research, we investigated the possibility of three TCMs, baicalin, ginsenoside Rg1, and puerarin, to modify the expression of miRNAs that affect the proliferation of ESCs. The current study demonstrated that only baicalin significantly suppressed the mESC proliferation and was accompanied with the G1 arrest, S phase suppression, and the downregulation of proto-oncogenes c-jun and c-fos. Treatment of cells with this flavone resulted in downregulation of miR-294 expression in mESCs while overexpression of miR-294 in mESCs reversed the alterations in the mESC proliferation and the expression of c-jun and c-fos induced by baicalin. Baicalin has been used for the treatment of inflammation, cardiovascular disease and microbial infections [7] . Its antitumor activity has also been reported in a variety of human cancer cell lines [8] [9] [10] . This activity is demonstrated by the baicalin induced cell cycle arrest and growth suppression [8] . Similarly, baicalin significantly increases the fraction of G0-G1 phase cells, but decreases the numbers of G2-M and S phase cells in vascular smooth muscle cells (VSMCs). Inhibition of cell proliferation by baicalin is due to its ability to reduce proliferating cell nuclear antigen (PCNA) expression and to elevate p27 levels in a concentration-dependent manner, coinciding with cell cycle arrest [12] . The present study showed that baicalin inhibited ESCs proliferation. The findings that baicalin inhibited ESC proliferation with increase in G1-phase cells and decrease in S phase cells were in good agreement with the observations in cancer cells and VSMCs.
The proto-oncogenes, c-myc, c-fos, and c-jun, can influence positive regulators of cell cycle such as Cyclin and Cdk binding [7] . c-myc together with other factors can induce somatic cells to become pluripotent stem cells and its abnormal expression in somatic cells is often associated with the occurrence and development of tumors [17] . c-jun and c-fos are often associated with c-myc in the development of cancer and may be used as indicators of cell proliferation as they alter the expression levels of factors and genes directly associated with cell growth [7] . Whether c-jun and c-fos can act as detectors of cell proliferation genes as well as play important roles in ESCs proliferation is unclear. The present study, however, showed that baicalin 50 μM significantly reduced c-jun and c-fos, which might account for the results of ESCs proliferation analysis and the cell cycle analysis.
Self-renewal capacity and proliferation in ESCs are maintained by a shortening of their cell cycle that leads to a rapid cell division [18, 19] . miR-290 cluster plays an important role in the proliferation of mouse embryonic stem cells (mESCs) by regulating the cell cycle [20] . The present data showed that miR-294 was suppressed by baicalin. Overexpression of miR-294 reversed the alterations in the mESC proliferation and the expression of c-jun and c-fos induced by baicalin. MiR-294 may regulate p21 protein (Cdc42/Rac)-activated kinase 7 (Pak7) and mitogen-activated protein kinase 8 (MAKP8) expression. Pak7 plays an important role in the process of signal transduction as a class of protein factors [3] . MAKP8, also called JNK1, can bind with the downstream signaling elements of the c-jun (junD, c-jun, ATF-Smad4, p53) to promote cell proliferation [3] . Although c-jun and c-fos are not the direct gene targets of miR-294, they may associate with JNK signal transduction pathways to regulate the downstream targets therefore participate in the regulation of proliferation of ESCs. In the present study, baicalin downregulated miR-294, thereby regulating c-jun and c-fos expression and inhibition of ESCs proliferation. This mechanism may also propose a new perspective of baicalin activity in cancer therapy. Further research is warranted to firmly establish the present study findings and explore more opportunities for the use of baicalin as a research tool and as a therapeutic agent in the treatment of diseases. The present study was limited to murine embryonic stem cells which may reduce its generalizability to human applications because substantial differences between animal models and humans exist (21) . However, the findings of this work adds a piece of knowledge to the understanding of baicalin action and therefore further studies with human embryonic stem cells or human induced pluripotent stems cells are needed to extend the findings of the present study.
In summary, baicalin significantly suppressed mESC proliferation which was accompanied with G1 arrest, S phase suppression and the down-regulation of proto-
